Cipla launches drug to treat H1N1 virus

In: H1N1

9 Feb 2010

Drug maker Cipla Ltd on Wednesday launched its generic version of Roche’s Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement. Cipla’s Oseltamivir brand, called Antiflu, will cost 475 rupees for 10 capsules, with 75 ml syrup will be similarly priced.

Random Posts

Comment Form

About this blog

This is a Collection of global news on all the swine flu!

Photostream